Christopher Bunka, Director at Lexaria Bioscience Corp. (LEXX), bought 27,500 shares at $0.92 ($25K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.92 | 15,600 | $14K | 57.0% |
| 2 | $0.91 | 11,900 | $11K | 43.0% |
| Total | $0.92 avg | 27,500 | $25K | 100% |
| Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |
| LXRP | BUY | 2016-08-25 | $3K | — | Filing → |